American Oncology Network & Sarah Cannon Research Institute Expand Cancer Research Collaboration with Addition of Genesis Cancer and Blood Institute

Oct 7, 2021

American Oncology Network, LLC and Sarah Cannon Research Institute announced today the addition of AON partner practice Genesis Cancer and Blood Institute, as a strategic research site.

Howard A. "Skip" Burris, III, MD

American Oncology Network, LLC (AON) and Sarah Cannon Research Institute announced today the addition of AON partner practice Genesis Cancer and Blood Institute (Genesis), as a strategic research site. Hematology/Oncology Clinic in Baton Rouge, La., Messino Cancer Centers in Asheville, N.C., and Zangmeister Cancer Center in Columbus, Ohio, all partner practices of AON, are also strategic research sites under this partnership, which brings greater access to cutting-edge therapies through clinical trials for patients.

For close to 30 years, Genesis has been participating in clinical trials. This new partnership with Sarah Cannon Research Institute will provide patients access to an expanded menu of clinical trials and advanced therapies. Genesis Medical Oncologists serving patients in Hot Springs are Dr. Timothy Webb, Dr. Robert T. Muldoon, Dr. Stephen “Fred” Divers, Dr. Lynn Cleveland and Dr. Lingyi Chen.

“The physicians at Genesis Cancer and Blood Institute are committed to delivering advanced treatment options for the best possible outcomes for their patients,” said AON CEO Todd Schonherz. “By partnering with Sarah Cannon Research Institute, we are combining our exceptional local physician expertise with internationally-recognized teams and research to improve care and match patients with potentially life-saving treatments while staying within the comfort and familiarity of their oncologist’s office.”

AON Vice President of Clinical Research Katie Goodman added, “In the world of oncology, clinical research is a major force in the advancement of treatments for different cancers. Clinical trials also help us improve the quality of life for patients during and after treatment.”

AON is currently comprised of an expanding network of partner practices across 17 states. AON practices offer in-house laboratory, pathology and oral pharmacy services all under one roof so that patients can receive the care they need in one location. Research has shown that having easy and convenient access to expert physician care and a comprehensive range of treatments and support services close to home is vital to a patient’s well-being. By collaborating with Sarah Cannon Research Institute, which is a global leader in offering community-based clinical trials, AON is providing opportunities for patients to participate in cutting-edge cancer research, while reducing the need to drive long distances or travel out of state for care.

Sarah Cannon Research Institute pioneered the first community-based oncology drug development program in the United States and has grown to become a global leader in early phase research, conducting more than 500 first-in-human studies to date. Through its efforts to advance therapies for patients, Sarah Cannon Research Institute has been a clinical trial leader in the majority of approved cancer therapies over the last decade.

“Through our partnership with AON, we are furthering our mission to bring cutting-edge therapies into the community so patients can stay close to home while accessing the treatment options they need,” said Howard A. “Skip” Burris, III, MD, President of Clinical Operations and Chief Medical Officer at Sarah Cannon. “We look forward to working together with the experts at Genesis Cancer and Blood Institute to offer clinical trials for people facing cancer in Hot Springs.”

Related Content